1. Combination of AURKA inhibitor and HSP90 inhibitor to treat breast cancer with AURKA overexpression and TP53 mutations
   Fuping Wang et al, 2022, Medical Oncology CrossRef
2. Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance
   Jian Zhang et al, 2022, Cells CrossRef
3. Therapeutic Potential of Heat Shock Protein 90 Inhibitors, Geldanamycin, and Analog Compounds in Precision Cancer Therapy
   Atta Mohammed Alzebari et al, 2023, BioMed Target Journal CrossRef